Medical Device Product Liability and the Rise of Digital Health/Artificial Intelligence
Webinar Series | Medical Device Discussion
Digital health technologies, including tools incorporating artificial intelligence, are rapidly becoming an important part of drug development and marketing strategies, as well as part of the pharmacovigilance, marketing, and disease diagnosis processes. These tools, which range from relatively simple mobile apps to highly sophisticated systems generating their own hypotheses and suggested solutions, present important opportunities to improve patient care. However, they also introduce new liability risks given the potential for inaccuracies and quality problems, limitations on the ability to step-in as AI systems evolve new capabilities, weaknesses that may skew AI machine learning and data, and the impact on the role of the learned intermediary. This webinar will focus on ensuring that product liability counsel understand the implications of these technologies and can manage these changes to minimize future product liability.
WEBINAR SERIES INFORMATION
As digital technologies and artificial intelligence continue to revolutionize the healthcare industry, navigating established legal and regulatory principles requires practical and innovative approaches across the care continuum. Key stakeholders, from providers, payors and patients to developers and regulatory and compliance personnel, are confronting rapidly changing healthcare delivery models, and these technologies have a direct impact on a spectrum of issues. These include medical devices regulation, coverage and reimbursement, healthcare compliance, advertising and promotion, privacy and data security, and litigation and risk management.
To better understand and navigate these complex legal and regulatory issues from both a US and an EU perspective, please join us for our timely and informative Medical Devices Webcast Discussion series. Our recognized global medical devices team, which combines diverse subject-matter experience with deep industry knowledge and innovative thinking, will share insights and best practices on issues ranging from digital technology investments, regulatory and healthcare compliance, product liability, antitrust litigation, and compliance risk management.
One hour of CA and NY CLE credit is pending for each session.